Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist to treat type 2 diabetes and is also used off-label for weight loss in people with obesity and overweight
This requires either a caloric deficit or high activity levels that create energy demand
Many chronic condition codes in Chapter 4 and wound codes in Chapter 12 will affect your risk-adjustment accuracy and DRG assignment
The PA process requires documentation of a confirmed T2D diagnosis, a recent HbA1c value (most plans require HbA1c 7.0%), evidence that metformin was tried first or is contraindicated, and the prescriber's clinical rationale for choosing a GLP-1 RA over other second-line agents
Shabbir Safdar, Executive Director, Partnership for Safe Medicines, said: Compounders operate on the outskirts of drug safety regulations and dont face the same stringent requirements. The briefing calls for compounders to meet the same FDA standards as drug manufacturers and for stricter enforcement of patent rights during market exclusivity periods
About Found Found is among the largest medically-supported weight care clinics in the country, serving more than 200,000 members to date
